Peter Van Hoogevest

Title: The Innovations of Peter Van Hoogevest

Introduction

Peter Van Hoogevest is a notable inventor based in Neustadt an der Weinstrasse, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral treatments. His work has led to the creation of a patent that showcases his innovative approach to addressing medical challenges.

Latest Patents

Peter Van Hoogevest holds a patent for a pharmaceutical composition containing an antivirally active dihydroquinazoline derivative. This invention relates to pharmaceutical compositions, especially for intravenous administration, which include a specific compound known as {8-fluoro-2-[4-(3-methoxyphenyl)piperazine-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-3,4-dihydroquinazoline-4-yl}acetic acid. This compound is combined with at least one of the cyclodextrin excipients, lysine, and arginine. The patent also details the method for its production and its application in treating illnesses, particularly as an antiviral agent against cytomegaloviruses. He has 1 patent to his name.

Career Highlights

Throughout his career, Peter has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Aicuris GmbH & Co. KG and Translational Cancer Drugs Pharma, S.L. His experience in these organizations has allowed him to contribute to significant advancements in drug development.

Collaborations

Peter has collaborated with various professionals in his field, including Kerstin Paulus and Wilfried Schwab. These partnerships have enhanced his research and development efforts, leading to innovative solutions in pharmaceuticals.

Conclusion

Peter Van Hoogevest is a distinguished inventor whose work in antiviral pharmaceutical compositions has made a notable impact in the medical field. His innovative spirit and collaborative efforts continue to drive advancements in healthcare.